大隐静脉机械化学腔内消融:当代结局观察
单中心回顾性研究分析了2015至2020年间104例机械化学消融(MOCA)手术,大隐静脉消融成功率92.7%,无学习曲线证据;血栓延伸至深静脉的发生率为14.6%,未报告肺栓塞并发症,作者认为MOCA是安全且技术成功率良好的手术。
要点
- 104例MOCA手术中,96例有术后随访,大隐静脉消融成功率92.7%(n=89),无时间性学习曲线证据。
- 89例技术成功消融的术后双功超声显示,美国静脉论坛(AVF)内皮热诱导血栓形成(EHIT)1级闭合77例(86.5%),2级3例(3.4%),3级8例(8.9%),4级1例。
- 19条因活动性静脉性溃疡治疗的患肢中,13条(68.4%)溃疡改善或愈合;未报告肺栓塞并发症。
核心结论
- MOCA的大隐静脉血栓形成成功率为92.7%,无学习曲线证据,与文献报道相当。
- 血栓延伸至深静脉的发生率为14.6%,抗凝治疗未出现相关不良效应,AVF EHIT 2级或以上无临床显著后遗症。
- 作者认为MOCA消融大隐静脉是安全的手术,可取得良好的技术成功。
研究设计与样本
- 单中心回顾性研究,回顾了2015年至2020年在大洛杉矶退伍军人事务医院接受的所有MOCA手术。
- 共对86例患者实施了104例静脉消融手术;11例(12.8%)患者接受双侧干预,6例(7%)患者同一腿接受非同期干预。
- 平均年龄58.4岁(标准差12),93%为男性。
主要发现
- 术前症状包括疼痛(102例,98.1%)、静脉曲张(87例,83.7%)、水肿(58例,55.8%)和活动性溃疡(19例,18.3%)。
- CEAP分类C2是最常见指征(34.6%),其次为C3(22.1%)和C6(21.2%);45例(43.2%)患者存在深静脉系统反流,53%同期行静脉切除术;平均VCSS评分为7.5(标准差3.5)。
- 96例有术后随访的手术中,大隐静脉消融率为92.7%(n=89),无时间性学习曲线证据。
- 89例技术成功消融的术后双功超声显示,77例(86.5%)为AVF EHIT 1级闭合,3例(3.4%)为2级,8例(8.9%)为3级,1例为4级。
- 14例(15.7%)患者新开始抗凝治疗,平均33.2天(标准差34.1);19条因活动性静脉性溃疡治疗的患肢中,13条(68.4%)溃疡改善或愈合;未报告肺栓塞并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,与文献中MOCA相关血栓延伸至深静脉的比较有限,因为术后筛查双功超声并非标准诊疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovenous ablation techniques have replaced greater saphenous vein (GSV) ligation and stripping for treatment of venous insufficiency. Our objective was to investigate our initial procedural experience and clinical presentation of patients undergoing mechanochemical ablation (MOCA) at a single institution. We hypothesized that closure level and success rate improved over time and were comparable to other endovenous ablation techniques. METHODS: We retrospectively reviewed all MOCA procedures performed at the Greater Los Angeles Veterans Affairs Hospital from 2015 - 2020. Variables included CEAP and VCSS scores, patient symptoms, post procedure duplex ultrasound, closure level, and need for anticoagulation. Success was defined as GSV thrombosis on initial post procedure duplex ultrasound. Procedure associated extension of thrombus into the deep veins was defined using the American Venous Forum (AVF) endothermal heat induced thrombosis (EHIT) classification. RESULTS: 104 venous ablation procedures were performed on 86 patients. Eleven (12.8%) patients received bilateral interventions, and six (7%) patients had asynchronous interventions on the same leg. The average age was 58.4 years (SD 12) and 93% were male. Pre-procedural symptoms included pain (102, 98.1%), varicose veins (87, 83.7%), edema (58, 55.8%), and active ulcers (19, 18.3%). A CEAP category of C2 was the most common indication (34.6%), followed by C3 (22.1%) and C6 (21.2%). Forty-five (43.2%) patients had deep system reflux, and 53% had concomitant phlebectomies. Average VCSS score was 7.5 (SD 3.5).We observed a GSV ablation rate of 92.7% (n = 89) in the 96 procedures which had post-procedure follow up, with no temporal evidence of a learning curve. On post procedure duplex of the 89 technically successful ablations, 77 (86.5%) patients had AVF EHIT level 1 closure, three (3.4%) had level 2 closure, eight (8.9%) had level 3 closure, and one had a level 4 closure. Fourteen (15.7%) patients were newly started on anticoagulation for an average of 33.2 days (SD 34.1). Of the 19 legs treated for active venous ulcers, 13 (68.4%) had improvement or resolution of their venous ulcers. No pulmonary embolic complications were reported. CONCLUSIONS: We observed a successful GSV thrombosis rate of 92.7% using MOCA without evidence of a learning curve and comparable to that reported in the literature. The rate of thrombus extension into the deep veins was 14.6%, with no adverse effects associated with anticoagulation or clinically significant sequelae of AVF EHIT level 2 or greater. Comparisons with MOCA associated thrombus extension into deep veins in the literature are limited as post procedure screening duplex are not standard of care. However, we demonstrated that MOCA ablation of the GSV is a safe procedure that may be performed with good technical success.
引用
- Chen AJ, Ulloa JG, Torrez T, et al. Mechanochemical Endovenous Ablation of the Saphenous Vein: A Look at Contemporary Outcomes. Ann Vasc Surg. 2021. PMID: 34933109. doi:10.1016/j.avsg.2021.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。